Evaluating Prethrombotic State In Lung Cancer Using Molecular Markers
- 1 January 1993
- journal article
- Published by Elsevier BV in Chest
- Vol. 103 (1), 196-200
- https://doi.org/10.1378/chest.103.1.196
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Fibrinolysis and CancerSeminars in Thrombosis and Hemostasis, 1990
- Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.Journal of Clinical Oncology, 1988
- Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitorBlood, 1987
- The significance of the fibrin/fibrinogen degradation product in serum of carcinoma patients with hematogenous metastasisCancer, 1986
- A New International Staging System for Lung CancerChest, 1986
- The Hypercoagulable StatesAnnals of Internal Medicine, 1985
- Cancer Metastasis: Experimental Approaches, Theoretical Concepts, and Impacts for Treatment StrategiesAdvances in Cancer Research, 1985
- Plasminogen Activators, Tissue Degradation, and CancerAdvances in Cancer Research, 1985
- The World Health Organization Histological Typing of Lung Tumours: Second EditionAmerican Journal of Clinical Pathology, 1982
- TROUSSEAUʼS SYNDROME AND OTHER MANIFESTATIONS OF CHRONIC DISSEMINATED COAGULOPATHY IN PATIENTS WITH NEOPLASMSMedicine, 1977